1. Coxsackievirus B3—Its Potential as an Oncolytic Virus
   Anja Geisler et al, 2021, Viruses CrossRef
2. A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study
   Ann W. Silk et al, 2023, Cancer Immunology, Immunotherapy CrossRef
3. Trial Watch—Oncolytic viruses and cancer therapy
   Jonathan Pol et al, 2016, OncoImmunology CrossRef
4. Oncolytic immunotherapy: The new clinical outbreak
   Jean-François Fonteneau et al, 2016, OncoImmunology CrossRef
5. The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
   Ibrahim Eissa et al, 2018, Cancers CrossRef
6. Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
   Yi-Ying Wu et al, 2023, Frontiers in Cellular and Infection Microbiology CrossRef
7. Viral Vector-Based Melanoma Gene Therapy
   Altijana Hromic-Jahjefendic et al, 2020, Biomedicines CrossRef
8. A physiologically based pharmacokinetic model for V937 oncolytic virus in mice
   Sara Peribañez-Dominguez et al, 2023, Frontiers in Pharmacology CrossRef
9. CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses
   Ming Yuan et al, 2016, Viruses CrossRef
10. Prior Exposure to Coxsackievirus A21 Does Not Mitigate Oncolytic Therapeutic Efficacy
    William J. Burnett et al, 2021, Cancers CrossRef
11. Oncolytic virus therapy in cancer: A current review
    Jonathan Santos Apolonio et al, 2021, World Journal of Virology CrossRef
12. Developing Picornaviruses for Cancer Therapy
    Cormac McCarthy et al, 2019, Cancers CrossRef
13. Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials
    June Kyu Hwang et al, 2020, International Journal of Molecular Sciences CrossRef
14. The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems
    Luyao Wang et al, 2022, Frontiers in Oncology CrossRef
15. Role of HMGB1 in Cutaneous Melanoma: State of the Art
    Federica Li Pomi et al, 2022, International Journal of Molecular Sciences CrossRef
16. Mechanistic Modeling of a Novel Oncolytic Virus, V937, to Describe Viral Kinetic and Dynamic Processes Following Intratumoral and Intravenous Administration
    Zinnia P. Parra-Guillen et al, 2021, Frontiers in Pharmacology CrossRef
17. Serotype-Specific Killing of Large Cell Carcinoma Cells by Reovirus
    Emily Simon et al, 2017, Viruses CrossRef
18. Oncolytic virus preclinical toxicology studies
    Agnija Rasa et al, 2023, Journal of Applied Toxicology CrossRef
19. Beyond Immunotherapy: Seizing the Momentum of Oncolytic Viruses in the Ideal Platform of Skin Cancers
    Dimitrios C. Ziogas et al, 2022, Cancers CrossRef